Takeda Pharmaceutical Revenue 2007-2020 | TAK

Takeda Pharmaceutical annual/quarterly revenue history and growth rate from 2007 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Takeda Pharmaceutical revenue for the quarter ending March 31, 2020 was $7.103B, a 59.82% increase year-over-year.
  • Takeda Pharmaceutical revenue for the twelve months ending March 31, 2020 was $30.279B, a 81.82% increase year-over-year.
  • Takeda Pharmaceutical annual revenue for 2020 was $30.279B, a 60.42% increase from 2019.
  • Takeda Pharmaceutical annual revenue for 2019 was $18.875B, a 18.45% increase from 2018.
  • Takeda Pharmaceutical annual revenue for 2018 was $15.935B, a 1.08% decline from 2017.
Takeda Pharmaceutical Annual Revenue
(Millions of US $)
2020 $30,279
2019 $18,875
2018 $15,935
2017 $16,108
2016 $15,001
2015 $16,178
2014 $16,917
2013 $18,843
2012 $19,163
2011 $17,101
2010 $15,763
2009 $15,697
2008 $13,748
2007 $11,061
2006 $10,361
Takeda Pharmaceutical Quarterly Revenue
(Millions of US $)
2020-03-31 $7,103
2019-12-31 $7,906
2019-09-30 $7,543
2019-06-30 $7,727
2018-12-31 $4,445
2018-06-30 $4,138
2017-06-30 $4,034
2016-06-30 $4,036
2015-06-30 $3,660
2015-03-31 $3,673
2014-12-31 $4,153
2014-09-30 $4,076
2014-06-30 $4,017
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $4,171
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $5,089
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
2010-03-31 $3,728
2009-09-30 $2
2009-03-31 $3,594
2008-03-31 $2,839
2007-03-31 $2,525
2006-03-31 $2,371
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $57.916B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.920B 41.95
Astellas Pharma (ALPMY) Japan $29.770B 15.08
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 20.80
Merck (MKGAF) Germany $17.008B 22.31
Catalent (CTLT) United States $13.659B 52.80
Grifols, S.A (GRFS) Spain $13.050B 15.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.669B 0.00
Neurocrine Biosciences (NBIX) United States $11.206B 43.38
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.253B 43.88
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.115B 10.14
United Therapeutics (UTHR) United States $5.067B 11.71
Arrowhead Pharmaceuticals (ARWR) United States $4.490B 490.22
Hypermarcas (HYPMY) Brazil $4.287B 15.77
Evotec AG (EVTCY) Germany $4.065B 109.55
Nektar Therapeutics (NKTR) United States $3.902B 0.00
FibroGen (FGEN) United States $3.729B 0.00
ChemoCentryx (CCXI) United States $3.359B 0.00
PTC Therapeutics (PTCT) United States $3.175B 0.00
Sage Therapeutics (SAGE) United States $2.585B 0.00
Cronos Group (CRON) Canada $2.477B 70.80
Taro Pharmaceutical Industries (TARO) Israel $2.457B 11.89
Pacira BioSciences (PCRX) United States $2.328B 47.65
Corcept Therapeutics (CORT) United States $1.798B 17.83
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.787B 0.00
Xencor (XNCR) United States $1.763B 0.00
Indivior (INVVY) United States $1.721B 21.36
USANA Health Sciences (USNA) United States $1.711B 16.12
Ironwood Pharmaceuticals (IRWD) United States $1.550B 11.86
Heron Therapeutics (HRTX) United States $1.532B 0.00
Akebia Therapeutics (AKBA) United States $1.425B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.395B 15.03
Revolution Medicines (RVMD) United States $1.388B 0.00
Zogenix (ZGNX) United States $1.340B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.276B 0.00
Karyopharm Therapeutics (KPTI) United States $1.152B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Esperion Therapeutics (ESPR) United States $1.091B 0.00
Tilray (TLRY) Canada $1.086B 0.00
VAXART, INC (VXRT) United States $0.970B 0.00
Translate Bio (TBIO) United States $0.968B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.954B 596.13
Altimmune (ALT) United States $0.902B 0.00
Endo (ENDP) Ireland $0.804B 1.25
BioCryst Pharmaceuticals (BCRX) United States $0.746B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
ImmunoGen (IMGN) United States $0.692B 0.00
Trillium Therapeutics (TRIL) Canada $0.613B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Radius Health (RDUS) United States $0.564B 0.00
Aerie Pharmaceuticals (AERI) United States $0.541B 0.00
Siga Technologies (SIGA) United States $0.535B 0.00
Flexion Therapeutics (FLXN) United States $0.517B 0.00
Molecular Templates (MTEM) United States $0.510B 0.00
TherapeuticsMD (TXMD) United States $0.505B 0.00
Ardelyx (ARDX) United States $0.505B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.497B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.478B 18.63
Crinetics Pharmaceuticals (CRNX) United States $0.467B 0.00
DURECT (DRRX) United States $0.454B 0.00
Ocular Therapeutix (OCUL) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 10.32
Rigel Pharmaceuticals (RIGL) United States $0.415B 0.00
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.395B 0.00
Calithera Biosciences (CALA) United States $0.352B 0.00
Harpoon Therapeutics (HARP) United States $0.327B 0.00
IMV INC (IMV) Canada $0.318B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.310B 0.00
PROFOUND MEDICL (PROF) Canada $0.296B 0.00
OptiNose (OPTN) United States $0.295B 0.00
MEI Pharma (MEIP) United States $0.290B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.269B 0.00
Redhill Biopharma (RDHL) Israel $0.261B 0.00
Lannett Co Inc (LCI) United States $0.250B 5.49
CASI Pharmaceuticals (CASI) United States $0.232B 0.00
Rafael Holdings (RFL) United States $0.221B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
Taiwan Liposome (TLC) Taiwan $0.197B 0.00
Nivalis Therapeutics (ALPN) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 25.03
Onconova Therapeutics (ONTX) United States $0.186B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
Heat Biologics (HTBX) United States $0.180B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.90
Matinas Biopharma Holdings (MTNB) United States $0.161B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.139B 0.00
Xeris Pharmaceuticals (XERS) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Otonomy (OTIC) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
CTI BioPharma (CTIC) United States $0.107B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.106B 0.00
Biomerica (BMRA) United States $0.106B 0.00
Recro Pharma (REPH) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
MediWound (MDWD) Israel $0.102B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.094B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.091B 0.00
Hemispherx BioPharma (AIM) United States $0.091B 0.00
Lipocine (LPCN) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
CV Sciences (CVSI) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Sundial Growers (SNDL) Canada $0.064B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.059B 0.00
AgeX Therapeutics (AGE) United States $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.049B 0.00
IsoRay (ISR) United States $0.046B 0.00
GTx (ONCT) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Natural Alternatives (NAII) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.06
NovaBay Pharmaceuticals (NBY) United States $0.041B 0.00
Jaguar Animal Health (JAGX) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.73
Can-Fite Biopharma (CANF) Israel $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 34.71
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Vical (BBI) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00